Atlas FDA

remede® System

FDA premarket approval P160039 · decided 2017-10-06

Approval details

PMA number
P160039
Trade name
remede® System
Generic name
Implanted phrenic nerve stimulator for central sleep apnea
Applicant
Respicardia
Date received
2016-09-06
Decision date
2017-10-06
Days to decision
395 days
Decision code
APPR
Product code
PSR
Advisory committee
Anesthesiology
Expedited review
No
Location
Minnetonka, MN
Statement
Approval for the remed® System. This device is an implantable phrenic nerve stimulator indicated for the treatment of moderate to severe central sleep apnea (CSA) in adult patients.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
RESPIGUIDE DELIVERY SYSTEM (K130378)Respicardia2013-10-17